Bisdemethoxycurcumin, a novel potent polyphenolic compound, effectively inhibits the formation of amyloid aggregates in ALS-associated hSOD1 mutant (L38R).

MLA

Kouhi, Zeinab Haghgoo, et al. “Bisdemethoxycurcumin, a Novel Potent Polyphenolic Compound, Effectively Inhibits the Formation of Amyloid Aggregates in ALS-Associated HSOD1 Mutant (L38R).” International Journal of Biological Macromolecules, vol. 282, no. Pt 2, Dec. 2024, p. 136701. EBSCOhost, https://doi.org/10.1016/j.ijbiomac.2024.136701.

APA

Kouhi, Z. H., Seyedalipour, B., Hosseinkhani, S., & Chaichi, M. J. (2024). Bisdemethoxycurcumin, a novel potent polyphenolic compound, effectively inhibits the formation of amyloid aggregates in ALS-associated hSOD1 mutant (L38R). International Journal of Biological Macromolecules, 282(Pt 2), 136701. https://doi.org/10.1016/j.ijbiomac.2024.136701

Chicago

Kouhi, Zeinab Haghgoo, Bagher Seyedalipour, Saman Hosseinkhani, and Mohammad Javad Chaichi. 2024. “Bisdemethoxycurcumin, a Novel Potent Polyphenolic Compound, Effectively Inhibits the Formation of Amyloid Aggregates in ALS-Associated HSOD1 Mutant (L38R).” International Journal of Biological Macromolecules 282 (Pt 2): 136701. doi:10.1016/j.ijbiomac.2024.136701.